We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$484B
AUM Growth
+$13.2B
Cap. Flow
-$3.88B
Cap. Flow %
-0.8%
Top 10 Hldgs %
13.39%
Holding
2,630
New
93
Increased
1,078
Reduced
887
Closed
93

Sector Composition

Rank Sector Weight
1 Healthcare 21.05%
2 Consumer Discretionary 13.82%
3 Financials 13.14%
4 Industrials 11.9%
5 Technology 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPL
1826
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$732K ﹤0.01%
46,860
+5,300
+13% +$77K
MNR
1827
DELISTED
Monmouth Real Estate Investment Corp
MNR
$728K ﹤0.01%
65,482
+6,500
+11% +$74.5K
AXON
1828
Axon Enterprise
AXON
$50B
$727K ﹤0.01%
30,160
VSAT icon
1829
Viasat
VSAT
$11.4B
$727K ﹤0.01%
12,200
VALE icon
1830
Vale
VALE
$58.7B
$723K ﹤0.01%
127,910
-380,362
-75% -$2.76M
DRC
1831
DELISTED
DRESSER-RAND GROUP INC
DRC
$723K ﹤0.01%
9,000
-9,400
-51% -$761K
UMPQ
1832
DELISTED
Umpqua Holdings Corp
UMPQ
$721K ﹤0.01%
41,965
+4,300
+11% +$71K
MDU icon
1833
MDU Resources
MDU
$4.27B
$719K ﹤0.01%
88,603
+19,461
+28% +$165K
FR icon
1834
First Industrial Realty Trust
FR
$8.4B
$718K ﹤0.01%
33,500
VRE
1835
DELISTED
Veris Residential
VRE
$716K ﹤0.01%
37,134
CXP
1836
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$711K ﹤0.01%
26,300
TREX icon
1837
Trex
TREX
$5.1B
$709K ﹤0.01%
52,000
-2,040
-4% -$23.5K
HMN icon
1838
Horace Mann Educators
HMN
$2.1B
$708K ﹤0.01%
20,710
OZK icon
1839
Bank OZK
OZK
$5.7B
$702K ﹤0.01%
19,000
+1,800
+10% +$64.1K
WLK icon
1840
Westlake Corp
WLK
$10.2B
$701K ﹤0.01%
9,742
-541
-5% -$34.7K
PDM
1841
Piedmont Realty Trust
PDM
$1.2B
$700K ﹤0.01%
37,600
EWL icon
1842
iShares MSCI Switzerland ETF
EWL
$2.22B
$691K ﹤0.01%
20,800
+6,500
+45% +$212K
SNBR
1843
DELISTED
Sleep Number
SNBR
$688K ﹤0.01%
19,950
SYA
1844
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
$687K ﹤0.01%
29,273
+581
+2% +$13K
MGA icon
1845
Magna International
MGA
$18.7B
$684K ﹤0.01%
+12,800
New +$659K
SCSC icon
1846
Scansource
SCSC
$1.06B
$683K ﹤0.01%
16,800
+6,700
+66% +$254K
PEI
1847
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$682K ﹤0.01%
1,957
MFA
1848
MFA Financial
MFA
$931M
$679K ﹤0.01%
21,600
-2,300
-10% -$72.8K
ACIW icon
1849
ACI Worldwide
ACIW
$5.42B
$676K ﹤0.01%
31,200
LDOS icon
1850
Leidos
LDOS
$17.9B
$676K ﹤0.01%
16,100

Similar funds

T. Rowe Price Associates's Q1 2015 Portfolio in Review

As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
  • T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
  • T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
  • T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
  • T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
  • T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
  • T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.

Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.